[Contribution of Japan to develop new anticancer agents].
Many drugs developed in Japan have been started their clinical trials in USA and European countries. The clinical trials in Japan will be requested the strict standard in accordance with the introduction of ICH-GCP. It is strongly requested for the medical student to be educated on the importance and methodology of clinical trials at university.
Sajjo
N
N
Pharmacology Division, National Cancer Center Research Institute, Japan.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017321:Clinical Trials, Phase I as Topic; D006801:Humans; D007564:Japan; D008495:Medical Oncology / Q000193:education; D009369:Neoplasms / Q000188:drug therapy
D000970:Antineoplastic Agents